華懋科技(603306.SH):選舉吳黎明爲董事長任命其爲公司法定代表人
格隆匯2月24日丨華懋科技(603306.SH)公佈,爲保證公司董事會正常運行,基於公司的戰略發展規劃,根據《公司法》《公司章程》等有關法律法規的規定,公司於2025年2月24日以現場結合通訊的方式召開了2025年第二次臨時董事會會議,審議通過了《關於選舉吳黎明先生爲公司董事長並任命公司法定代表人的議案》,同意選舉公司董事吳黎明先生爲公司第六屆董事會董事長並任命其爲公司法定代表人,任職期限自本次董事會審議通過之日起至第六屆董事會任期屆滿之日止。公司將按照有關規定辦理法定代表人變更登記等事項。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.